Correlation Between Transcode Therapeutics and Cognition Therapeutics
Can any of the company-specific risk be diversified away by investing in both Transcode Therapeutics and Cognition Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Transcode Therapeutics and Cognition Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Transcode Therapeutics and Cognition Therapeutics, you can compare the effects of market volatilities on Transcode Therapeutics and Cognition Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Transcode Therapeutics with a short position of Cognition Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Transcode Therapeutics and Cognition Therapeutics.
Diversification Opportunities for Transcode Therapeutics and Cognition Therapeutics
-0.67 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Transcode and Cognition is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Transcode Therapeutics and Cognition Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cognition Therapeutics and Transcode Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Transcode Therapeutics are associated (or correlated) with Cognition Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cognition Therapeutics has no effect on the direction of Transcode Therapeutics i.e., Transcode Therapeutics and Cognition Therapeutics go up and down completely randomly.
Pair Corralation between Transcode Therapeutics and Cognition Therapeutics
Given the investment horizon of 90 days Transcode Therapeutics is expected to under-perform the Cognition Therapeutics. In addition to that, Transcode Therapeutics is 2.61 times more volatile than Cognition Therapeutics. It trades about -0.03 of its total potential returns per unit of risk. Cognition Therapeutics is currently generating about 0.0 per unit of volatility. If you would invest 182.00 in Cognition Therapeutics on November 5, 2024 and sell it today you would lose (110.00) from holding Cognition Therapeutics or give up 60.44% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Transcode Therapeutics vs. Cognition Therapeutics
Performance |
| Timeline |
| Transcode Therapeutics |
| Cognition Therapeutics |
Transcode Therapeutics and Cognition Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Transcode Therapeutics and Cognition Therapeutics
The main advantage of trading using opposite Transcode Therapeutics and Cognition Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Transcode Therapeutics position performs unexpectedly, Cognition Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cognition Therapeutics will offset losses from the drop in Cognition Therapeutics' long position.| Transcode Therapeutics vs. Xenetic Biosciences | Transcode Therapeutics vs. Reviva Pharmaceuticals Holdings | Transcode Therapeutics vs. Eyenovia | Transcode Therapeutics vs. Cognition Therapeutics |
| Cognition Therapeutics vs. Reviva Pharmaceuticals Holdings | Cognition Therapeutics vs. Eyenovia | Cognition Therapeutics vs. Transcode Therapeutics | Cognition Therapeutics vs. Kodiak Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |